rev Antibody

Code: CSB-PA319405XA01HMA

Rate （N/A）
Review （0）

Size:

0.1ml

0.1ml1ml

US$Enquire

Quantity:

Species Reactivity: Human immunodeficiency virus type 2 subtype A (isolate SBLISY) (HIV-2)

Raised in: Rabbit

Application: ELISA, WB (ensure identification of antigen)

Send an Inquiry

Start an on-line Chat

Online ordering is currently available for U.S. customers only. For orders outside the U.S., please kindly submit an inquiry or start a chat with us.

Product Details
Related Products
Customer Reviews and Q&A
Target Background

Product Details

Uniprot NO.

P12448

Target Names

rev

Alternative Names

rev antibody; Protein Rev antibody; Regulator of expression of viral proteins antibody

Raised in

Rabbit

Species Reactivity

Human immunodeficiency virus type 2 subtype A (isolate SBLISY) (HIV-2)

Immunogen

Recombinant Human immunodeficiency virus type 2 subtype A (isolate SBLISY) (HIV-2) rev protein

Conjugate

Non-conjugated

Isotype

IgG

Purification Method

Antigen Affinity Purified

Concentration

It differs from different batches. Please contact us to confirm it.

Buffer

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4

Tested Applications

ELISA, WB (ensure identification of antigen)

Lead Time

Made-to-order (14-16 weeks)
Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.

Value-added Deliverables

① 200ug * antigen (positive control);
② 1ml * Pre-immune serum (negative control);

Quality Guarantee

① Antibody purity can be guaranteed above 90% by SDS-PAGE detection;
② ELISA titer can be guaranteed 1: 64,000;
③ WB validation with antigen can be guaranteed positive;

Datasheet & COA

Antibody FAQs

Related Products

Customer Reviews and Q&A

■ Customer Reviews

Submit a Review here

Target Background

Function(From Uniprot)

Escorts unspliced or incompletely spliced viral pre-mRNAs (late transcripts) out of the nucleus of infected cells. These pre-mRNAs carry a recognition sequence called Rev responsive element (RRE) located in the env gene, that is not present in fully spliced viral mRNAs (early transcripts). This function is essential since most viral proteins are translated from unspliced or partially spliced pre-mRNAs which cannot exit the nucleus by the pathway used by fully processed cellular mRNAs.

Subcellular Location

Host nucleus, host nucleolus. Host cytoplasm.

Promotions

Reward For Reviews

Free trial size antibodies

Contact Us

Email: support@cusabio.com
Distributors Worldwide

Service

Phage Display Service

Antibody Service

Protein Service

Gene Synthesis Service

Oligo Synthesis Service

Related Articles

Client Literature Review IF=52.7: Targeting SKAP2 Restores Sperm Motility and Morphology by Regulating Mitochondrial Organization and Cytoskeletal Remodeling Sincere Collaboration: A Review of CUSABIO's 2025 Annual Citations Across Borders, Built on Trust. CUSABIO 2025 Year-in-Review CUSABIO Monthly Citation Review: 280 New Product Citations in November, Total Citations Hit 29,000!CUSABIO Monthly Citation Review: 260 New Product Citations in October, Total Citations Hit 28,500!CUSABIO Quarterly Citation Review: 800 New Product Citations in Q3, Total Citations Hit 27,500!CUSABIO Monthly Citation Review: 240 New Product Citations in August, Total Citations Hit 27,200!CUSABIO Monthly Citation Review: 240 New Product Citations in July, Total Citations Hit 27,000!CUSABIO Quarterly Citation Review: 800 New Product Citations in Q2, Total Citations Hit 27,000!CUSABIO Monthly Citation Review: 240 New Product Citations in May, Total Citations Hit 26,800!CUSABIO Monthly Citation Review: 260 New Product Citations in April, Total Citations Hit 26,500!CUSABIO Quarterly Citation Review: 800 New Product Citations in the First Quarter, Total Citations Hit 26,000!CUSABIO Monthly Citation Review: 200 New Product Citations in February, Total Citations Hit 25,000!CUSABIO Monthly Citation Review: 220 New Product Citations in January, Total Citations Reach 24,500!Advancing Together: A Review of CUSABIO's 2024 Annual Citations 2024 Review: CUSABIO's Innovation and Growth CUSABIO Monthly Citations Review: November 2024, Over 230 Citations with an Impact Factor Exceeding 1200, Totaling 24,100 Articles!CUSABIO Monthly Citations Review: October 2024, Over 240 Citations with an Impact Factor Exceeding 1200, Totaling 23,800 Articles!CUSABIO Quarterly Citations Review: Q3 2024, Over 720 Citations with an Impact Factor Exceeding 3500, Totaling 23,600 Articles!CUSABIO Monthly Citations Review: In August, 240 High-Impact Citations, 23,400 Total Articles!CUSABIO Monthly Citations Review:240 High-Impact Citations, 23,200 Total Articles!CUSABIO Quarterly Citations Review: 800 High-Impact Citations, 23000 Total Articles!CUSABIO May Citations Review: 260 High-Impact Citations, Cumulative Impact Factor Exceeds 1200+!CUSABIO April Citations Review: 300 High-Impact Citations, Cumulative Impact Factor Exceeds 1500+!CUSABIO Quarterly Citations Review: 918 High-Impact Citations, Cumulative Impact Factor Exceeds 5000+!CUSABIO Annual Literature Review: 2000+ High-Impact Papers, Cumulative Impact Factor Exceeds 10,000+!CUSABIO Quarterly Literature Review: Over 1000 High Impact Factor Papers, Cumulative Impact Factor Surpasses 4000+!CUSABIO Semi-annual Literature Review: Consolidating 1500+ High Impact Factor Papers, Cumulative Impact Factor Exceeds 5000+!Exhibition Preview | CUSABIO Invites You to Meet at PEGS Boston 2023 Song Wei's team reveals the pathogenesis of cancer cachexia: gut-kidney immune axis and uric acid metabolism A Review of WFDC8 Antibody A Review of A Human NGAL (LCN2) ELISA Kit Proteolysis Targeting Chimera (PROTAC): A "Revolutionary" Technology in Small Molecule Drug Discovery!The Review of Post-translational Modifications A unique retinal model reveals the genetic basis of macular degeneration A new method for finding compounds to prevent aging Growth hormone works to prevent weight loss Preventing brain tumors from repairing themselves by blocking a protein Inhibiting oncogenic proteins can prevent scleroderma fibrosis Gene therapy can durably reverse congenital deafness in mice TASIN represents a promising approach for prevention of colorectal cancer A visit from REVCORP in Malaysia How to Choose an Antibody for Scientific Research?How to Choose? Polyclonal, Monoclonal, or Recombinant Antibody?The difference between primary antibody and secondary antibod How to Choose the Right Secondary Antibody?How to Validate An Antibody？How to Choose the Loading Control Antibodies?How to Choose An Appropriate Isotype Control Antibody?How to Choose Monoclonal Antibody Technology? A Definitive Guide The Overview of Recombinant Antibody A Comprehensive Guide to Monoclonal Antibody Production

Call us

301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)

Email

support@cusabio.com

Address

No. 269, Shendun 5th Road, Donghu Hi-Tech Development Area, Hubei Province, 430206, P.R.China

Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.

© 2007-2025 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1

▲ Select 0 Products